Synoptical view

    Truffle investment
    € 25M
vexim.jpg

In summary

Vexim is working on the development and commercialization of a revolutionary vertebral implant for the treatment of vertebral fractures by minimally invasive surgery.

As with most of the companies in its portfolio, Truffle Capital supported the company's development until the technology was commercialized. This model allows a consistent execution of the business plan, an optimal alignment of the management teams with Truffle Capital and gives the CEO the opportunity to focus his efforts on the technical and commercial success of the project.

In video

They talk about it

The company's flagship product is SpineJack, an implant that can repair a serious vertebral fracture in 30 minutes. A surgeon can insert this prosthesis into the spine through a simple small hole.

abivax_xbx64.jpg

Next start-up

Abivax